Anand Bhaskar
Insider CIK 1890784 · RETA VP, Chief Accounting Officer · SMMT Chief Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SMMT Summit Therapeutics Inc. | A Award | 2026-10-08 | 2026-10-14 | 100,000 | — | $0 | 261,047 | SEC↗ |
| SMMT Summit Therapeutics Inc. | A Award deriv | 2026-01-08 | 2026-01-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SMMT Summit Therapeutics Inc. | A Award | 2025-10-21 | 2025-10-23 | 26,680 | $18.74 | $500.0K | 159,751 | SEC↗ |
| SMMT Summit Therapeutics Inc. | A Award deriv | 2025-09-18 | 2025-09-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SMMT Summit Therapeutics Inc. | A Award deriv | 2025-04-29 | 2025-05-01 | 600,000 | — | $0 | 600,000 | SEC↗ |
| SMMT Summit Therapeutics Inc. | A Award deriv | 2025-04-29 | 2025-05-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SMMT Summit Therapeutics Inc. | A Award deriv | 2025-01-12 | 2025-01-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SMMT Summit Therapeutics Inc. | A Award | 2024-09-11 | 2024-09-13 | 22,026 | $22.70 | $500.0K | 131,426 | SEC↗ |
| SMMT Summit Therapeutics Inc. | A Award deriv | 2024-04-02 | 2024-04-04 | 600,000 | — | $0 | 600,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 33,500 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 23,438 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 6,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 15,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer | 2023-09-26 | 2023-09-26 | 24,089 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-09-05 | 2023-09-07 | 406 | $169.20 | $68.7K | 24,089 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-08-16 | 2023-08-17 | 210 | $168.42 | $35.4K | 24,495 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-08-15 | 2023-08-17 | 193 | $169.06 | $32.6K | 24,705 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-06-14 | 2023-06-16 | 1,562 | — | $0 | 23,438 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise | 2023-06-14 | 2023-06-16 | 1,562 | $27.32 | $42.7K | 27,241 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-06-14 | 2023-06-16 | 2,343 | $102.11 | $239.2K | 24,898 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-05-16 | 2023-05-17 | 136 | $81.10 | $11.0K | 25,679 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-05-15 | 2023-05-17 | 950 | $85.98 | $81.7K | 25,815 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-03-07 | 2023-03-08 | 165 | $84.58 | $14.0K | 26,765 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-03-03 | 2023-03-06 | 820 | $87.47 | $71.7K | 26,930 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-03-01 | 2023-03-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2023-03-01 | 2023-03-02 | 3,000 | — | $0 | 27,750 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-01-03 | 2023-01-04 | 33,500 | — | $0 | 33,500 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2023-01-03 | 2023-01-04 | 8,250 | — | $0 | 24,750 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-01-03 | 2022-01-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2022-01-03 | 2022-01-05 | 12,500 | — | $0 | 16,500 | SEC↗ |